| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Daniel Karen L serves as a Director at TDOC and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 0 buys and 8 sells. Those positions are worth an estimated $1.5M at current prices.
Historically, Daniel Karen L's trades have earned a middling insider score of 61/100 across 8 rated trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of +18.3%.
The biggest single holding is CBSH (~$1.1M) as Director.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2025 | SNA Snap-On Inc | Director | Sell | 1,090 | $319.92 | $348,716.18 | -12.0% | +0.9% | +19.0% | |
| May 23, 2024 | TDOC Teladoc Health, Inc. | Director | Sale+OE10b5-1 | 9,834 | $11.90 | $117,024.60 | -21.0% | -35.5% | -40.5% | |
| Dec 20, 2023 | TDOC Teladoc Health, Inc. | Director | Sell10b5-1 | 14,073 | $21.41 | $301,302.93 | -27.6% | -26.7% | -56.2% | |
| Mar 8, 2023 | SNA Snap-On Inc | Director | Sell | 2,046 | $245.38 | $502,056.69 | -20.3% | +6.4% | +19.2% | |
| May 19, 2022 | TDOC Teladoc Health, Inc. | Director | Sell | 410 | $31.18 | $12,783.80 | -0.9% | +9.2% | -27.7% | |
| Dec 9, 2021 | SNA Snap-On Inc | Director | Sell | 2,259 | $213.56 | $482,439.95 | -18.3% | -3.1% | +11.3% | |
| Nov 22, 2021 | TDOC Teladoc Health, Inc. | Director | Sale+OE | 109 | $115.33 | $12,570.97 | -0.3% | -40.1% | -74.5% | |
| Sep 9, 2021 | SNA Snap-On Inc | Director | Sell | 3,219 | $222.30 | $715,583.70 | -20.6% | -1.9% | +3.4% |